Cannabis Report
Home > Boards > US OTC > Biotechs > Nutra Pharma Corp. (NPHC)

Everybody needs to read this... This is from the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
maverick81 Member Profile
Member Level 
Followed By 300
Posts 4,924
Boards Moderated 1
Alias Born 01/03/17
160x600 placeholder
maverick81 Member Level  Thursday, 03/08/18 09:55:00 PM
Re: fly_fisherman post# 31907
Post # of 37251 
Everybody needs to read this...





This is from the PR today where Rik clearly lays out what this is all for...

"This will allow us to fulfill our commitments to our noteholders AS WELL AS FINALIZE LEGITIMATE LONG-TERM FINANCING to move the Company forward. The use of this financing includes retail marketing for our OTC products as well as clinical research for our drug products for the treatment of autoimmune diseases and viruses,” he concluded

Now read it again... let it sink in....
Then read it one more time...

Understand that raising the AS does not mean it is automatic never ending dilution hitting the market tomorrow...

Sounds like the 4 Bil shares are going to basically be used as collateral towards the financing package Rik finalizing, and the 20 million preferreds ( equals the other 2 billion) issued which will be used for partnerships and aquisitions or for additional directors to the board.


This is all good news. Yet it is confusing for most to put all the pieces together. Nothing is changed. Still way UNDERVALUED as we stand today. And major developments are still on their way.


Again the raise in AS will be used too :

 "finalize legitimate, long-term and non-toxic financing to move the Company forward. The use of this financing includes retail marketing for our OTC products as well as clinical research for our drug products for the treatment of autoimmune diseases and viruses,”



Mav




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist